summit study tirzepatide American Heart Association Scientific Sessions 2024 has started off with a bang! Results are in for the study: Treatment with (Mounjaro/ Zepbound) was associated with 38% ⬇️ in combined risk SURPASS to SURMOUNT: The Tirzepatide
Description
Lotte Bjerre Knudsen, chief scientific advisor in research and early development at Novo Nordisk, discusses the past and future of GLP-1s and related anti-obesity drugs.
For marketers, this shows that even highly regulated industries can enter mainstream conversation when timing, context, and audience are aligned.
Learn what is the average and how to maximise your results.
Together, they support healthy glucose metabolism, natural GLP-1 production, and effective belly fat reduction
Lose up to 20 lbs in 30 days with medically supervised Weight Loss Injections in Lantana FL Book your consultation at Majestic Aesthetics today
